Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 117, 228-237
Abstract
No abstract availableKeywords
Funding Information
- Shanghai ‘‘ChenGuang’’ Project (16CG42)
- Shanghai Municipal Commission of Health and Family Planning (2017YQ052)
- China Association for Science and Technology
- National Natural Science Foundation of China (31671214, 81502978, 81673352, 41576157, U1405227)
- University of Jinan (XKY1609)
- Young Taishan Scholars Program (tsqn20161037)
- Shandong Provincial Talents Team Cultivation Plan of University Preponderant Discipline (10027)
This publication has 40 references indexed in Scilit:
- Resveratrol Alleviates Endotoxin-Induced Myocardial Toxicity via the Nrf2 Transcription FactorPLOS ONE, 2013
- Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanismBioorganic & Medicinal Chemistry, 2013
- Small Molecule Modulators of Keap1‐Nrf2‐ARE Pathway as Potential Preventive and Therapeutic AgentsMedicinal Research Reviews, 2012
- Identification of a Novel Family of BRAFV600E InhibitorsJournal of Medicinal Chemistry, 2012
- Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome InhibitorsJournal of Medicinal Chemistry, 2012
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interactionFree Radical Biology and Medicine, 2012
- Targeting NRF2 signaling for cancer chemopreventionToxicology and Applied Pharmacology, 2010
- MyocarditisNew England Journal of Medicine, 2009
- Practical demethylation of aryl methyl ethers using an odorless thiol reagentArchives of Pharmacal Research, 2008
- Active defense under oxidative stress. The antioxidant responsive elementBiochemistry (Moscow), 2006